BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36182796)

  • 1. TKF, a mexicanolide-type limonoid derivative, suppressed hepatic stellate cells activation and liver fibrosis through inhibition of the YAP/Notch3 pathway.
    Yang T; Wu E; Zhu X; Leng Y; Ye S; Dong R; Liu J; Zhong J; Zheng Y; Xu W; Luo J; Kong L; Zhang H
    Phytomedicine; 2022 Dec; 107():154466. PubMed ID: 36182796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation.
    Ge MX; Liu HT; Zhang N; Niu WX; Lu ZN; Bao YY; Huang R; Yu DK; Shao RG; He HW
    Br J Pharmacol; 2020 Jan; 177(2):372-387. PubMed ID: 31621893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation.
    Lu ZN; Niu WX; Zhang N; Ge MX; Bao YY; Ren Y; Guo XL; He HW
    Acta Pharmacol Sin; 2021 Nov; 42(11):1808-1820. PubMed ID: 34465912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1-mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation.
    Zhu X; Ye S; Yu D; Zhang Y; Li J; Zhang M; Leng Y; Yang T; Luo J; Chen X; Zhang H; Kong L
    Br J Pharmacol; 2021 Sep; 178(17):3428-3447. PubMed ID: 33864382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy.
    Ge M; Liu H; Zhang Y; Li N; Zhao S; Zhao W; Zhen Y; Yu J; He H; Shao RG
    Br J Pharmacol; 2017 May; 174(10):1147-1160. PubMed ID: 28257144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The flavonoid GL-V9 alleviates liver fibrosis by triggering senescence by regulating the transcription factor GATA4 in activated hepatic stellate cells.
    Zhao J; Bai D; Qi L; Cao W; Du J; Gu C; Zhou C; Gao Y; Zhang L; Zhao Y; Lu N
    Br J Pharmacol; 2023 Apr; 180(8):1072-1089. PubMed ID: 36455594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
    Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis.
    Bhattacharya D; Basta B; Mato JM; Craig A; Fernández-Ramos D; Lopitz-Otsoa F; Tsvirkun D; Hayardeny L; Chandar V; Schwartz RE; Villanueva A; Friedman SL
    JHEP Rep; 2021 Jun; 3(3):100237. PubMed ID: 34151243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
    Li J; Dong S; Ye M; Peng G; Luo J; Wang C; Wang J; Zhao Q; Chang Y; Wang H
    Dig Dis Sci; 2021 Jan; 66(1):143-150. PubMed ID: 32144602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cordycepin alleviates hepatic fibrosis in association with the inhibition of glutaminolysis to promote hepatic stellate cell senescence.
    Liang Z; Zhang K; Guo H; Tang X; Chen M; Shi J; Yang J
    Int Immunopharmacol; 2024 May; 132():111981. PubMed ID: 38565039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4
    Ye L; Ziesch A; Schneider JS; Ofner A; Nieß H; Denk G; Hohenester S; Mayr D; Mahajan UM; Munker S; Khaled NB; Wimmer R; Gerbes AL; Mayerle J; He Y; Geier A; Toni EN; Zhang C; Reiter FP
    Aging Dis; 2024 Feb; 15(1):338-356. PubMed ID: 37307826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions.
    Yang J; Tang X; Liang Z; Chen M; Sun L
    Clin Mol Hepatol; 2023 Apr; 29(2):465-481. PubMed ID: 36800698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
    Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant adeno-associated virus-mediated transfer of shRNA against Notch3 ameliorates hepatic fibrosis in rats.
    Zheng SP; Chen YX; Guo JL; Qi D; Zheng SJ; Zhang SL; Weng ZH
    Exp Biol Med (Maywood); 2013 Jun; 238(6):600-9. PubMed ID: 23918872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation.
    Mannaerts I; Leite SB; Verhulst S; Claerhout S; Eysackers N; Thoen LF; Hoorens A; Reynaert H; Halder G; van Grunsven LA
    J Hepatol; 2015 Sep; 63(3):679-88. PubMed ID: 25908270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
    Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
    J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-571 affects the development and progression of liver fibrosis by regulating the Notch3 pathway.
    Cong S; Liu Y; Li Y; Chen Y; Chen R; Zhang B; Yu L; Hu Y; Zhao X; Mu M; Cheng M; Huang Z
    Sci Rep; 2021 Nov; 11(1):21854. PubMed ID: 34750395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N; Perumal M; Halagowder D; Sivasithamparam N
    Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.